期刊文献+

糖蛋白Ⅱb/Ⅲa受体拮抗剂的研究进展

下载PDF
导出
摘要 血小板膜糖蛋白IIb/IIIa(GPⅡb/Ⅲa)是血小板聚集的最终共同途径中的关键因素,特别是在动脉血栓形成过程中起着重要作用,因此阻断GP IIb/IIIa受体是治疗和预防血栓性疾病的重要措施。本文针对药物的作用途径及作用靶点,综述了近年来作用于血小板糖蛋白Ⅱb/Ⅲa受体拮抗剂的抗血小板聚集作用药物的研究进展。
作者 陈增修
出处 《中国医药指南》 2012年第13期68-70,共3页 Guide of China Medicine
  • 相关文献

参考文献13

二级参考文献46

  • 1陈玉国,李瑞建,张运.血小板糖蛋白Ⅱb/Ⅲa受体拮抗剂在急性心肌梗死冠状动脉介入中的研究进展[J].心血管病学进展,2006,27(5):624-626. 被引量:2
  • 2Braumvald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of pat/eats with unstable angina and non-ST-segment elevation myocardial infarction-summary article:a report of the American College of Cardiology/American Heart Association task force on practice guidelines ( Committee on the Management of Patients With Unstable Angina) [ J]. J Am Coll Cardiol,2002,40 ( 7 ) : 1366 -1374. 被引量:1
  • 3Monagle P,Chan A, Massicotte P, et al. Antithrombotic therapy in children: the seventh ACCP conference on antithrombotic and thrombolytic Therapy [ J ]. Chest, 2004, 126 (3 Suppl ): 645S-687S. 被引量:1
  • 4Lefkovits J, Topoi EJ. Platelet glycoprotein Ⅱb/Ⅲa receptor antagonists in coronary artery disease [ J ]. Eur Heart J, 1996,17 ( 1 ) : 9-18. 被引量:1
  • 5Le Breton H,Plow EF,Topol EJ. Role of platelets in restenosis after percutaneous coronary revascularization [ J ]. J AM Coll Candiol, 1996,28(7) : 1643-1651. 被引量:1
  • 6Popma JJ,Berber P, Ohman EM, et al. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Antithrombotie therapy during percutaneous coronary intervention[J].Chest, 2004,126(3 Suppl) :576S-599S. 被引量:1
  • 7Zhang L, Zhang ZG, Zhang C, et al. Intravenous administration of a GPⅡb/Ⅲa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model [ J ]. Stroke,2004,35 ( 12 ) :2890-2895. 被引量:1
  • 8Seitz R J, Hamzavi M ,Junghans U, et al. Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke:preliminary observations[ J ]. Stroke ,2003,34 ( 8 ) : 1932-1935. 被引量:1
  • 9Straub S, Junghans U, Jovanovic V, et al. Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion [ J ]. Stroke, 2004,35 ( 3 ) : 705 -709. 被引量:1
  • 10Abou-Chebl A, Bajzer CT, Krieger DW, et al. Multimodal therapy for the treatment of severe ischemic stroke combining GP Ⅱb/Ⅲa antagonists and angioplasty after failure of thrombolysis [ J ]. Streke,2005,36(10) :2286-2288. 被引量:1

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部